Research on A Medicine Doesn't End on the Initial Approval by the FDA. Eli Lilly and Company's Chief Medical Officer Shares Why Ongoing Research Helps Us Better Understand A Medicine’s Full Value.

Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA). In fact, that’s when post-approval research and monitoring begin and they help all health care stakeholders, including physicians and patients, to better understand the full value of the medicine.